Literature DB >> 16022053

The Dartmouth COOP Charts: a simple, reliable, valid and responsive quality of life tool for chronic obstructive pulmonary disease.

T Eaton1, P Young, W Fergusson, J E Garrett, J Kolbe.   

Abstract

The negative impact of chronic obstructive pulmonary disease (COPD) on health-related quality of life (HRQL) is substantial. Measurement of HRQL is increasingly advocated in clinical practice; traditional outcome measures such as lung function are poorly responsive. However many HRQL tools are not user-friendly in the clinic setting. Hence HRQL is often neglected. The Dartmouth Cooperative Functional Assessment Charts (COOP) have the requisite attributes of a tool suitable for routine clinical practice: they are simple, reliable, quick and easy to perform and score and well accepted. We aimed to determine the reliability, validity and responsiveness of the COOP in patients with significant COPD. HRQL was assessed during a prospective, randomised, placebo-controlled, double-blind, 12 week cross-over interventional study of ambulatory oxygen in patients (n = 50) with COPD. Test-retest reliability of the COOP domains was only modest however it was measured over a 2 month period. Significant correlations ranging between 0.4 and 0.8 were observed between all comparable domains of the COOP and the Medical Outcomes Study 36-item Short-form Health Survey, Chronic Respiratory Questionnaire (CRQ) and Hospital Anxiety and Depression (HAD) scale. Following ambulatory oxygen significant improvements were noted in all CRQ and HAD domains. Several domains of the generic SF-36 (role emotional, social functioning, role-physical) showed significant improvements. Comparable domains of the COOP (social activities, feelings) also showed significant improvements. The COOP change in health domain improved very significantly. The COOP is a simple, reliable HRQL tool which proved valid and responsive in our study population of COPD patients and may have a valuable role in routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16022053     DOI: 10.1007/s11136-004-0624-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  33 in total

1.  Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease.

Authors:  C A Ketelaars; M A Schlösser; R Mostert; H Huyer Abu-Saad; R J Halfens; E F Wouters
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

2.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock; P Littlejohns
Journal:  Am Rev Respir Dis       Date:  1992-06

3.  An empirical comparison of four generic health status measures. The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument.

Authors:  M L Essink-Bot; P F Krabbe; G J Bonsel; N K Aaronson
Journal:  Med Care       Date:  1997-05       Impact factor: 2.983

4.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors:  P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal:  BMJ       Date:  2000-05-13

5.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients.

Authors:  D A Redelmeier; A M Bayoumi; R S Goldstein; G H Guyatt
Journal:  Am J Respir Crit Care Med       Date:  1997-04       Impact factor: 21.405

6.  Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme.

Authors:  P Young; M Dewse; W Fergusson; J Kolbe
Journal:  Aust N Z J Med       Date:  1999-02

Review 7.  Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease.

Authors:  J R Curtis; R A Deyo; L D Hudson
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

8.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

9.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

10.  Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study.

Authors:  T Eaton; J E Garrett; P Young; W Fergusson; J Kolbe; S Rudkin; K Whyte
Journal:  Eur Respir J       Date:  2002-08       Impact factor: 16.671

View more
  8 in total

1.  Community-based exercise programs for cancer survivors: a scoping review of practice-based evidence.

Authors:  Kelley R Covington; Mary C Hidde; Mackenzi Pergolotti; Heather J Leach
Journal:  Support Care Cancer       Date:  2019-08-16       Impact factor: 3.603

Review 2.  Patient-reported physical activity questionnaires: a systematic review of content and format.

Authors:  Kate Williams; Anja Frei; Anders Vetsch; Fabienne Dobbels; Milo A Puhan; Katja Rüdell
Journal:  Health Qual Life Outcomes       Date:  2012-03-13       Impact factor: 3.186

3.  Could vitamin d have a potential anti-inflammatory and anti-infective role in bronchiectasis?

Authors:  Jim Bartley; Jeff Garrett; Cameron C Grant; Carlos A Camargo
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

4.  Application of the COOP/WONCA charts to aged patients with chronic obstructive pulmonary disease: a comparison between Japanese and Chinese populations.

Authors:  Midori Yamaguchi; Motoyuki Nakao; Hideto Obata; Hideki Ikeda; Tetsuro Kanda; Qiao Wang; Yoriko Hara; Hisamitsu Omori; Yoko Ishihara
Journal:  BMC Public Health       Date:  2013-08-15       Impact factor: 3.295

Review 5.  A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges.

Authors:  Mario Cazzola; Nicola Alexander Hanania; William MacNee; Katja Rüdell; Claire Hackford; Nihad Tamimi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-04-07

6.  Vitamin D3 supplementation in adults with bronchiectasis: A pilot study.

Authors:  Jim Bartley; Jeff Garrett; Carlos A Camargo; Robert Scragg; Alain Vandal; Rose Sisk; David Milne; Ray Tai; Gene Jeon; Ray Cursons; Conroy Wong
Journal:  Chron Respir Dis       Date:  2018-02-28       Impact factor: 2.444

7.  Protocol for a feasibility trial to inform the development of a breathlessness rehabilitation programme for chronic obstructive pulmonary disease and chronic heart failure (the COHERE trial).

Authors:  Amy V Jones; Rachael A Evans; Dale W Esliger; Lauren B Sherar; Sally J Singh
Journal:  BMJ Open       Date:  2019-07-16       Impact factor: 2.692

8.  Integrating patients with chronic respiratory disease and heart failure into a combined breathlessness rehabilitation programme: a service redesign and pilot evaluation.

Authors:  Emma Chaplin; Sarah Ward; Enya Daynes; Claire LA Bourne; Amy Stenson; Amye Watt; Nikki Gardiner; Linzy Houchen-Wolloff; Sally J Singh
Journal:  BMJ Open Respir Res       Date:  2021-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.